News & Analysis as of

Abbreviated New Drug Application (ANDA) › Hatch-Waxman › Drug Approvals

Robins Kaplan LLP

ANDA Approvals

Robins Kaplan LLP on

New Drug Applications and 505(B)(2) Applications - This chart tracks the date, drug, reference-listed company, and applicant of Abbreviated New Drug Applications and 505(b)(2) Applications receiving final approval by the FDA....more

Robins Kaplan LLP

ANDA Approvals - Winter 2018

Robins Kaplan LLP on

Please see Chart below for more information....more

Robins Kaplan LLP

Generic Launches - Fall 2018

Robins Kaplan LLP on

Please see Chart below for more information. ...more

3 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide